Koichi Ichimura
- Genetics top 0.05%
- Glioma Diagnosis and Treatment 138
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 28
- Neurology top 0.5%
- Neuroblastoma Research and Treatments 23
- Neurofibromatosis and Schwannoma Cases 21
- Oncology top 1%
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 28
-
- Meningioma and schwannoma management 24
-
- Chromatin Remodeling and Cancer 21
-
- Sarcoma Diagnosis and Treatment 17
- Co-authors
- V. Peter CollinsEsther SchmidtDanita M. PearsonDavid JonesSylvia KocialkowskiL. Magnus BäcklundGuido ReifenbergerYoshitaka Narita
- Cited by
- GeneticsCancer ResearchNeurology
- Journals
- Brain Tumor Pathology (29 papers)Neuro-Oncology (13 papers)Journal of Neuro-Oncology (10 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Koichi Ichimura
252 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Genetics 4.4k
- Cancer Research 2.3k
- Neurology 1.7k
- Oncology 2.5k
- Pathology and Forensic Medicine 1.5k
Countries citing papers authored by Koichi Ichimura
This map shows the geographic impact of Koichi Ichimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Ichimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Ichimura more than expected).
Fields of papers citing papers by Koichi Ichimura
This network shows the impact of papers produced by Koichi Ichimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Ichimura. The network helps show where Koichi Ichimura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Koichi Ichimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 12 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 25 | |
| 8 | 2019 | 7 | |
| 9 | 2019 | 41 | |
| 10 | The mutant IDH1 inhibitor prevents growth of glioblastoma with IDH1 mutation in patient-derived xenograft (PDX) model | 2016 | 0 |
| 11 | 2015 | 39 | |
| 12 | 2013 | 88 | |
| 13 | Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomasbreakdown → | 2008 | 609 |
| 14 | 2008 | 21 | |
| 15 | 2008 | 27 | |
| 16 | 2008 | 119 | |
| 17 | 2008 | 12 | |
| 18 | 2003 | 27 | |
| 19 | 1998 | 108 | |
| 20 | Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. | 1993 | 494 |
About Koichi Ichimura
Koichi Ichimura is a scholar working on Genetics, Neurology and Cancer Research, having authored 263 papers that have together received 9.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (138 papers), Cancer Genomics and Diagnostics (28 papers), Lymphoma Diagnosis and Treatment (28 papers), Meningioma and schwannoma management (24 papers), Neuroblastoma Research and Treatments (23 papers), Chromatin Remodeling and Cancer (21 papers), Neurofibromatosis and Schwannoma Cases (21 papers) and Sarcoma Diagnosis and Treatment (17 papers). The work is most often cited by research in Genetics (4.4k citations), Cancer Research (2.3k citations) and Neurology (1.7k citations). Koichi Ichimura has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include V. Peter Collins, Esther Schmidt, V. Peter Collins, Danita M. Pearson, David Jones, Sylvia Kocialkowski, L. Magnus Bäcklund, Guido Reifenberger, Yoshitaka Narita and G. Reifenberger. Their work appears in journals such as Brain Tumor Pathology, Neuro-Oncology, Journal of Neuro-Oncology, Modern Pathology and Journal of Neuropathology & Experimental Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.